Qiagen Confidently Forecasts 2025 Earnings to Reach $2.35 per Share

Qiagen, a leading provider of molecular diagnostics solutions, has revised its 2025 earnings projections upwards. This positive adjustment comes on the heels of impressive first-quarter sales exceeding expectations and ongoing favorable market conditions. Qiagen’s adjusted diluted earnings per share (EPS) are now projected to hit approximately $2.35, up from a previous forecast of $2.28.